1. Admission blood glucose level as an ischemic stroke risk modifier in patients with new-onset non-valvular atrial fibrillation. (25th November 2020) Authors: Bergamaschi, L; Donati, F; Paolisso, P; Bartoli, L; Angeli, F; Stefanizzi, A; Toniolo, S; Magnani, I; D'Angelo, E.C; Foa', A; Rinaldi, A; Martignani, C; Biffi, M; Pizzi, C; Galie', N Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adverse outcomes after worsening renal function in patients with atrial fibrillation: the Fushimi AF Registry. (25th November 2020) Authors: Ogawa, H; An, Y; Ikeda, S; Aono, Y; Doi, K; Hamatani, Y; Fujino, A; Ishii, M; Iguchi, M; Masunaga, N; Esato, M; Wada, H; Hasegawa, K; Abe, M; Akao, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Age-adjusted risk factors are independently associated with an increased risk of ischaemic stroke, transient ischaemic stroke and systemic embolism in the ETNA-AF-Europe registry. (14th October 2021) Authors: De Caterina, R; De Groot, J.R; Weiss, T.W; Kelly, P; Monteiro, P; Deharo, J.C; De Asmundis, C; Lopez-De-Sa, E; Waltenberger, J; Steffel, J; Levy, P; Bakhai, A; Pecen, L; Kirchhof, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Are all CHA2DS2-VASc risk factors created equal? An assessment of stroke risk among 34, 470 patients with CHA2DS2-VASc scores of 1 or 2. (25th November 2020) Authors: Zweibel, S; Passman, R; Sarkar, S; Koehler, J; Ziegler, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of left ventricular end-diastolic diameter with incidence of thromboembolism in patients with non-valvular atrial fibrillation: the Fushimi AF Registry. (14th October 2021) Authors: Tezuka, Y; Doi, K; Hamatani, Y; An, Y; Ishii, M; Iguchi, M; Masunaga, N; Esato, M; Wada, H; Hasegawa, K; Ogawa, H; Abe, M; Akao, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry. (25th November 2020) Authors: Apenteng, P; Fitzmaurice, D.A; Virdone, S; Camm, A.J; Fox, K.A.A; Bassand, J.-P; Goldhaber, S.Z; Goto, S; Haas, S; Turpie, A.G.G; Verheugt, F.W.A; Misselwitz, F; Kayani, G; Pieper, K.S; Kakkar, A.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Frequency of cardioversions for atrial fibrillation and the risk ischemic stroke. (25th November 2020) Authors: Jaakkola, S; Kiviniemi, T.O; Jaakkola, J; Pouru, J.P; Nuotio, I; Vasankari, T; Hartikainen, J.E.K; Airaksinen, K.E.J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry. (14th October 2021) Authors: Bassand, J; Virdone, S; Verheugt, F.W.A; Camm, A.J; Cools, F; Fox, K.A.A; Goldhaber, S.Z; Goto, S; Haas, S; Hacke, W; Kayani, G; Misselwitz, F; Pieper, K.S; Turpie, A.G.G; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of polypharmacy on clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry. (14th October 2021) Authors: Yamashita, T Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of the introduction of an integrated multi-professional pathway for atrial fibrillation on long-term outcomes. (14th October 2021) Authors: Aslam, S; Vickers, C; Veevers, W; Farrar, L; Hartley, L; Viswanathan, K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗